Early NCPAP Before Surfactant Treatment in Very Preterm Infants With RDS

C

Central South University

Status

Completed

Conditions

Preterm Infants,
Nasal Continuous Positive Airway Pressure,
Respiratory Distress Syndrome,
Bronchopulmonary Dysplasia
Surfactant Treatment,

Study type

Observational

Funder types

Other

Identifiers

NCT01996670
huohuiyi20131121
huo20131121 (Registry Identifier)

Details and patient eligibility

About

We hypothesis a period of early NCPAP before surfactant treatment is effective for treating RDS and preventing BPD in very premature infants.

Enrollment

683 patients

Sex

All

Ages

30 minutes to 2 hours old

Volunteers

No Healthy Volunteers

Inclusion criteria

All enrolled infants were able to breathe at 5 min of age, had evidence of respiratory distress, unable to receive surfactant therapy, and were administrated with early NCPAP as the initial treatment

Exclusion criteria

Exclusion criteria were endotracheal intubation for resuscitation or insufficient respiratory drive, died in the first 24 hours after birth, known genetic disorders, potentially life-threatening conditions unrelated to prematurity, and premature rupture of membranes (PROM) for >3 weeks.

Trial design

683 participants in 3 patient groups

<2h group
2-4h group
>4h group

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems